Moving toward assured access to treatment in microbicide trials
2006
Access to Treatment in Microbicide Trials
publication
Author Information
Author(s): Anna Forbes
Primary Institution: Global Campaign for Microbicides
Conclusion
The Global Campaign for Microbicides emphasizes the need for assured access to treatment for participants who seroconvert during trials.
Supporting Evidence
- Public concern about ethics in HIV-prevention trials has intensified recently.
- Two clinical trials testing tenofovir were halted due to ethical concerns.
- The Global Campaign for Microbicides aims to ensure access to new HIV-prevention options.
- Access to care is a critical factor for the continuation of microbicide trials.
- UNAIDS has called for a task force to develop mechanisms for ART access.
Takeaway
This study talks about how important it is to make sure people in HIV prevention trials get the treatment they need if they get sick during the study.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website